MK-1029
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 08, 2011
Study to evaluate the safety, tolerability, and pharmacokinetics of MK-1029 in participants with mild to moderate asthma
(clinicaltrials.gov)
- P1, N=27; Not yet recruiting
Asthma
1 to 1
Of
1
Go to page
1